American Society of Health System Pharmacists 2015

American Society of Health System Pharmacists 2015

DAY 5
Celebrating 50 Years of ASHP Midyear
The American Society of Health-System Pharmacists has just finished celebrating 50 years of its Midyear Clinical Meeting.
DAY 4
Why Should Pharmacists Report to MedWatch?
Teresa Rubio, PharmD, of the FDA Office on Health and Constituents outlines why it is important for pharmacists to report to MedWatch.
What Are Currently Some of the Major Trends in Pharmacy?
James Hoffman, PharmD, MS, FASHP of St. Jude Children's Research Hospital, discusses some of the major trends in pharmacy. This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.
What Pharmacists Should Know about the Duration of DAPT
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, professor in the department of clinical and administrative sciences at Sullivan University College of Pharmacy, discusses what pharmacists should know about the duration of dual antiplatelet therapy.
How the Type of Antiplatelet Agents Can Impact Patient Outcomes
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, professor in the department of clinical and administrative sciences at Sullivan University College of Pharmacy, discusses how the type of antiplatelet agent chosen can impact patient outcomes.
The Role of the Pharmacist in Counseling Patients with ACS
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, professor in the department of clinical and administrative sciences at Sullivan University College of Pharmacy, discusses the importance of counseling patients with acute coronary syndrome.
How the Type of Stent Used Impacts the Duration of DAPT
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, professor in the department of clinical and administrative sciences at Sullivan University College of Pharmacy, discusses how the type of stent used impacts the duration of dual antiplatelet therapy.
What Pharmacists Need to Know About Post-Stent DAPT
Do you know the current guidelines for using dual antiplatelet therapy after drug-eluting stent implantation?
3 Exotic Diseases Pharmacists Should Know
Pharmacists should learn how to properly diagnose foreign-acquired diseases in order to optimize outcomes for infected patients.
The Role of the Pharmacist in ACS Management with Platelet Aggregation Inhibitors
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, professor in the department of clinical and administrative sciences at Sullivan University College of Pharmacy, discusses what the role of the pharmacist is in acute coronary syndrome management with platelet aggregation inhibitors.
DAY 3
Tips to Spot Medication Errors Outside the Hospital Pharmacy
Identifying medication use risks outside the hospital pharmacy requires something simple: speaking with other members of the health care team.
2016 Pharmacy Forecast: More Patient Empowerment
Health-system pharmacists must look beyond immediate operational challenges and consider the larger trends that will ultimately affect their practices.
How Patient Empowerment Is Affecting Pharmacy Practice
James Hoffman, PharmD, MS, FASHP of St. Jude Children's Research Hospital, describes how the growing trend of patient empowerment will affect the practice of pharmacy going forward.
Using Platelet Aggregation Inhibitors in Different Patient Populations
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the different nuances pharmacists have to consider when using platelet aggregation inhibitors in different patient populations.
DAY 2
An Overview of the Types of Burns a Patient Can Sustain
Patrick Dougherty, PharmD, BCPS,clinical pharmacist at the Emergency Medicine Peninsula Regional Medical Center, provides an overview of the various types of burns a patient can sustain.
Challenging and Memorable Burn Cases
Patrick Dougherty, PharmD, BCPS, a clinical pharmacist at the Emergency Medicine Peninsula Regional Medical Center, talks about some memorable experiences he has had with burn patients.
What Pharmacists Should Report to FDA MedWatch
Pharmacists should take advantage of the FDA's adverse drug event reporting system to promote patient safety.
Role of the Pharmacist in ACS Management with Platelet Aggregation Inhibitors
Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses the pharmacist's role in acute coronary syndrome management with platelet aggregation inhibitors.
Health-System Pharmacists: What's in Your Crash Cart?
Certain items are must-haves in any crash cart during a hospital code.
How Pharmacists Can Provide Help in Cardiopulmonary Resuscitation Efforts
Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses some ways pharmacists can help in cardiopulmonary resuscitation efforts.
Typical Medications in a Crash Cart
Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, talks about what is inside a crash cart.
Documentation and Communication Pharmacists Can Provide in Emergency Situations
Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses the role pharmacists can play in emergency situations.
What a Crash Cart Contains Besides Medication
Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses what is in a crash cart beyond medications.
Acute Treatment of Minor Burns
Patrick Dougherty, PharmD, BCPS, a clinical pharmacist at the Emergency Medicine Peninsula Regional Medical Center, gives some examples of treatment for minor burns.
The Pharmacist's Role in Burn Management
Patrick Dougherty, PharmD, BCPS, a clinical pharmacist at the Emergency Medicine Peninsula Regional Medical Center, discusses how pharmacists can help burn patients.
DAY 1
Off-Label Uses for NOACs
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic gives examples of certain off-label uses for NOACs that seem promising.
Internal and External Factors That Can Affect Pharmacists' Reliability
Natasha Nicol, Pharm D, FASHP, director of Global Patient Safety Affairs at Cardinal Health, discusses internal and external factors that could affect pharmacists' reliability.
Pharmacist Role in ACS Management with Platelet Aggregation Inhibitors
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the role of the pharmacist in ACS management with platelet aggregation inhibitors.
Pharmacists Can Reduce Medication Errors During Emergency Codes
Health-system pharmacists can help save lives by reducing the risk of medication errors before, during, and after hospital emergency codes.
4 Things Pharmacists Should Know About Medical Marijuana
Should hospitals open their own medical marijuana dispensaries?
The Pharmacist's Role in Managing the Medication Process Outside the Pharmacy
Matthew C. Grissinger, RPh, FISMP, FASCP, director, of error reporting programs at the Institute for Safe Medication Practices, discusses what the pharmacist's role is in managing the medication process outside the pharmacy.
Role of Platelet Aggregation Inhibitors in ACS Management
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the role of platelet aggregation inhibitors in ACS management.
Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.